vimarsana.com
Home
Live Updates
Data From Incyte's Povorcitinib Clinical Program to Be Featu
Data From Incyte's Povorcitinib Clinical Program to Be Featu
Data From Incyte's Povorcitinib Clinical Program to Be Featured at the 8th Annual Symposium on Hidradenitis Suppurativa Advances (SHSA) | Business
WILMINGTON, Del.--(BUSINESS WIRE)--Oct 13, 2023--
Related Keywords
United States ,
Delaware ,
Phoenix ,
Arizona ,
Hidradenitis Suppurativa ,
Kurt Brown ,
Exchange Commission ,
European Academy Of Dermatology ,
National Center ,
Clinical Research ,
Global Program Head ,
Drug Development ,
Rare Diseases Information Center ,
Annual Symposium ,
Hidradenitis Suppurativa Advances ,
Associate Vice President ,
Placebo Controlled Phase ,
Friday October ,
Patient Characteristics Associated ,
Saturday October ,
Advancing Translational Science Genetic ,
Rare Diseases Information ,
Janus Kinase ,
European Academy ,
Business Wire ,
Business ,
Ews Ap ,